Kumar S - Search Results

1

Vascular endothelial growth factors and receptors in colorectal cancer: implications for anti-angiogenic therapy.

Duff SE, Jeziorska M, Rosa DD, Kumar S, Haboubi N, Sherlock D, O'Dwyer ST, Jayson GC. Duff SE, et al. Among authors: kumar s. Eur J Cancer. 2006 Jan;42(1):112-7. doi: 10.1016/j.ejca.2005.09.018. Eur J Cancer. 2006. PMID: 16321517

2

CD105 is important for angiogenesis: evidence and potential applications.

Duff SE, Li C, Garland JM, Kumar S. Duff SE, et al. Among authors: kumar s. FASEB J. 2003 Jun;17(9):984-92. doi: 10.1096/fj.02-0634rev. FASEB J. 2003. PMID: 12773481 Review.

3

Perfusion of 99Tcm-labeled CD105 Mab into kidneys from patients with renal carcinoma suggests that CD105 is a promising vascular target.

Costello B, Li C, Duff S, Butterworth D, Khan A, Perkins M, Owens S, Al-Mowallad AF, O'Dwyer S, Kumar S. Costello B, et al. Among authors: kumar s. Int J Cancer. 2004 Apr 10;109(3):436-41. doi: 10.1002/ijc.11699. Int J Cancer. 2004. PMID: 14961584

4

Quantification of vascular endothelial growth factor-C.

Al-Mowallad AF, Li C, Wilson P, Duff S, Costello B, Al Qozi A, Kumar S. Al-Mowallad AF, et al. Among authors: kumar s. J Immunol Methods. 2004 Jun;289(1-2):239-40. doi: 10.1016/j.jim.2004.03.001. J Immunol Methods. 2004. PMID: 15251428 No abstract available.

5

Mast cells in the pathogenesis of chronic back pain: a hypothesis.

Freemont AJ, Jeziorska M, Hoyland JA, Rooney P, Kumar S. Freemont AJ, et al. Among authors: kumar s. J Pathol. 2002 Jul;197(3):281-5. doi: 10.1002/path.1107. J Pathol. 2002. PMID: 12115872

6

Vascular endothelial growth factor-C in patients with breast cancer.

Al-Mowallad A, Kirwan C, Byrne G, McDowell G, Li C, Stewart A, Al-Qouzi A, Kumar S. Al-Mowallad A, et al. Among authors: kumar s. In Vivo. 2007 May-Jun;21(3):549-51. In Vivo. 2007. PMID: 17591368 Free article.

7

CD105 prevents apoptosis in hypoxic endothelial cells.

Li C, Issa R, Kumar P, Hampson IN, Lopez-Novoa JM, Bernabeu C, Kumar S. Li C, et al. Among authors: kumar s, kumar p. J Cell Sci. 2003 Jul 1;116(Pt 13):2677-85. doi: 10.1242/jcs.00470. Epub 2003 May 13. J Cell Sci. 2003. PMID: 12746487

8

A comparative study of neovascularisation in atherosclerotic plaques using CD31, CD105 and TGF beta 1.

Li C, Mollahan P, Baguneid MS, McMahon RF, Kumar P, Walker MG, Freemont AJ, Kumar S. Li C, et al. Among authors: kumar s, kumar p. Pathobiology. 2006;73(4):192-7. doi: 10.1159/000096020. Pathobiology. 2006. PMID: 17119348

9

Expression of PAX 3 alternatively spliced transcripts and identification of two new isoforms in human tumors of neural crest origin.

Parker CJ, Shawcross SG, Li H, Wang QY, Herrington CS, Kumar S, MacKie RM, Prime W, Rennie IG, Sisley K, Kumar P. Parker CJ, et al. Among authors: kumar s, kumar p. Int J Cancer. 2004 Jan 10;108(2):314-20. doi: 10.1002/ijc.11527. Int J Cancer. 2004. PMID: 14639621

10

Platelet release of Vascular Endothelial Growth Factor (VEGF) in patients undergoing chemotherapy for breast cancer.

Kirwan CC, Byrne GJ, Kumar S, McDowell G. Kirwan CC, et al. Among authors: kumar s. J Angiogenes Res. 2009 Oct 24;1:7. doi: 10.1186/2040-2384-1-7. J Angiogenes Res. 2009. PMID: 20016693 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31,987 results

Search Page

Filters